APRISO (Salix Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the APRISO drug offered from Salix Pharmaceuticals, Inc.. This Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Salix Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | mesalamine |
SUBSTANCE NAME: | MESALAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-10-31 |
END MARKETING DATE: | 0000-00-00 |
APRISO HUMAN PRESCRIPTION DRUG Details:
Item Description | APRISO from Salix Pharmaceuticals, Inc. |
LABELER NAME: | Salix Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 375(mg/1) |
START MARKETING DATE: | 2008-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65649-103_45105af2-1096-4b2b-a6b7-10643f9fe93c |
PRODUCT NDC: | 65649-103 |
APPLICATION NUMBER: | NDA022301 |
Other MESALAMINE Pharmaceutical Manufacturers / Labelers: